More than 18 months into the COVID-19 pandemic, there are still very few drugs authorized by the FDA to treat the virus. Just one drug, remdesivir, has gained full FDA approval as a treatment for COVID-19. (Becker's Hospital Review)
Becker's asked physicians from top health systems which medications they're using most frequently to treat their COVID-19 patients, which they're avoiding and which have been most effective.
Editor's note: Responses were edited lightly for length and clarity.
Question: Which drugs are you using most frequently to treat your COVID-19 patients?
Sanjana Koshy, MD, infectious diseases physician at Mount Sinai (New York City): We recommend dexamethasone for all our hospitalized patients requiring supplemental oxygen. This was based on the RECOVERY trial that showed a survival benefit in patients on supplemental oxygen. We have increasingly used tocilizumab in combination with dexamethasone in our severely ill hospitalized patients with rapidly increasing oxygen requirements. We continue to use remdesivir for our hospitalized patients on low-flow oxygen.
See full article here